Consolidated Statement of Changes in Equity

Note (20)	Interests of shareholders of BRAIN Biotech AG					Non-controlling interests
€ thousand	Subscribed capital	Capital reserves	Retained earnings	Other reserves Currency translation	Total	Total	Total
Balance as at 30 September 2021/1 October 2021	21,847	95,890	-79,509	555	38,783	3,044	41,828
Net loss for the reporting period	0	0	-6,590	0	-6,590	249	-6,341
Other comprehensive income	0	0	901	-227	674	-17	656
Total comprehensive income (loss)	0	0	-5,689	-227	-5,916	231	-5,685
Acquisition of shares of non-controlling shareholders	0	0	0	0	0	1,335	1,335
Addition of liability from put/call agreement relating to the acquisition of non-controlling interests in fully consolidated Group companies	0	-3,978	0	0	-3,978	0	-3,978
Transfers due to employee share scheme	0	748	0	0	748	0	748
Balance as at 30 September 2022/1 October 2022	21,847	92,660	-85,198	328	29,638	4,610	34,248
Net loss for the reporting period	0	0	-8,279	0	-8,279	165	-8,114
Other comprehensive income	0	0	25	299	324	-9	315
Total comprehensive income (loss)	0	0	-8,255	299	-7,956	156	-7,799
Exercise of put/call agreements for the acquisition of non-controlling interests in fully consolidated Group companies	0	0	1,795	0	1,795	-1,795	0
Acquisition of shares of non-controlling shareholders	0	0	-2,504	0	-2,504	-1,728	-4,232
Transfers due to employee share scheme	0	797	0	0	797	0	797
Balance as at 30 September 2023	21,847	93,457	-94,161	627	21,770	1,243	23,013